Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Sep;57 Suppl 19(Suppl 19):51-6.
doi: 10.1590/S0036-46652015000700010.

THE TREATMENT OF COCCIDIOIDOMYCOSIS

Neil M Ampel  1
Affiliations
Review

THE TREATMENT OF COCCIDIOIDOMYCOSIS

Neil M Ampel. Rev Inst Med Trop Sao Paulo. 2015 Sep.

Abstract
in English, Portuguese

Therapy of coccidioidomycosis continues to evolve. For primary pulmonary disease, antifungal therapy is frequently not required while prolonged courses of antifungals are generally needed for those in whom extrathoracic disseminated has occurred. Intravenous amphotericin B should be reserved for those with severe disease. Oral triazole antifungals have had a great impact on the management of coccidioidomycosis. Both fluconazole and itraconazole at 400 mg daily have been effective for various forms of coccidioidomycosis, including meningitis, although relapse after therapy is discontinued is a problem. Individuals with suppressed cellular immunity are at increased risk for symptomatic coccidioidomycosis and they include those with HIV infection, those on immunosuppressive medications, and those who have received a solid organ transplant. Pregnant women and African-American men have been identified as two other groups who are at an increased risk for symptomatic and severe infection.

A terapia da coccidioidomicose continua a evoluir. Para a doença pulmonar primária, o tratamento antifúngico frequentemente não é necessário, enquanto períodos prolongados de tratamento antifúngico são geralmente necessários para aqueles nos quais houve disseminação extratorácica. A anfotericina B intravenosa deve ser reservada para pacientes com doença grave. Antifúngicos triazólicos orais têm tido um grande impacto no manejo da coccidioidomicose. Tanto fluconazol quanto itraconazol em doses diárias de 400 mg foram eficazes contra várias formas de coccidioidomicose, incluindo a meníngea, embora recaídas após a interrupção da terapia ainda constituam um problema. Indivíduos com supressão da imunidade celular apresentam risco aumentado para a coccidioidomicose sintomática, incluindo pacientes infectados pelo HIV, em uso de medicações imunossupressoras, e os que receberam transplantes de órgãos sólidos. Mulheres grávidas e homens afro-americanos foram identificados como dois outros grupos que apresentam risco aumentado de infecção sintomática e grave.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Coccidioidal Peritonitis: A Review of 17 Cases.
    Johnson RH, Sharma R, Sharma R, Civelli V, Narang V, Kuran R, Goldstein EJC, Deresinski S, Jones A, Ramzan A, Posalski I, El-Sayed D, Thompson GR 3rd, D'Assumpcao C, Heidari A. Johnson RH, et al. Open Forum Infect Dis. 2022 Jan 19;9(3):ofac017. doi: 10.1093/ofid/ofac017. eCollection 2022 Mar. Open Forum Infect Dis. 2022. PMID: 35169589 Free PMC article. Review.
  • Coccidioidomycosis: first cases reported in Pernambuco, Brazil.
    Araújo PSR, Souza Junior VR, Padilha CE, Oliveira MI, Arraes LC, Vieira R, Antunes A, Lima Neto RG, Marsden A. Araújo PSR, et al. Rev Inst Med Trop Sao Paulo. 2018 Nov 14;60:e75. doi: 10.1590/S1678-9946201860075. Rev Inst Med Trop Sao Paulo. 2018. PMID: 30462798 Free PMC article.
  • Epidemiological, clinical, and genomic landscape of coccidioidomycosis in northeastern Brazil.
    Eulálio KD, Kollath DR, Martins LMS, Filho AD, Cavalcanti MDAS, Moreira LM, Tenório BG, Alves LGB, Yamauchi D, Barrozo LV, Thompson Iii GR, Nacher M, Stajich JE, Benard G, Bagagli E, Felipe MSS, Barker BM, Trilles L, Teixeira MM. Eulálio KD, et al. Nat Commun. 2024 Apr 12;15(1):3190. doi: 10.1038/s41467-024-47388-0. Nat Commun. 2024. PMID: 38609393 Free PMC article.
  • Diagnosis and Treatment of Fungal Infections in Lung Transplant Recipients.
    Escamilla JE, January SE, Vazquez Guillamet R. Escamilla JE, et al. Pathogens. 2023 May 10;12(5):694. doi: 10.3390/pathogens12050694. Pathogens. 2023. PMID: 37242364 Free PMC article. Review.
  • Valley Fever: Pathogenesis and Evolving Treatment Options.
    Zaheri SC, Field E, Orvin CA, Perilloux DM, Klapper RJ, Shelvan A, Ahmadzadeh S, Shekoohi S, Kaye AD, Varrassi G. Zaheri SC, et al. Cureus. 2023 Dec 10;15(12):e50260. doi: 10.7759/cureus.50260. eCollection 2023 Dec. Cureus. 2023. PMID: 38196429 Free PMC article. Review.
See all "Cited by" articles

References

    1. Ampel NM. Delayed-type hypersensitivity,in vitroT-cell responsiveness and risk of active coccidioidomycosis among HIV-infected patients living in the coccidioidal endemic area. Med Mycol. 1999;37:245–250. - PubMed
    1. Ampel NM. The complex immunology of human coccidioidomycosis. Ann N Y Acad Sci. 2007;1111:245–258. - PubMed
    1. Ampel NM, Dols CL, Galgiani JN. Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area. Am J Med. 1993;94:235–240. - PubMed
    1. Ampel NM, Giblin A, Mourani JP, Galgiani JN. Factors and outcomes associated with the decision to treat primary pulmonary coccidioidomycosis. Clin Infect Dis. 2009;48:172–178. - PubMed
    1. Ampel NM, Ryan KJ, Carry PJ, Wieden MA, Schifman RB. Fungemia due toCoccidioides immitis . An analysis of 16 episodes in 15 patients and a review of the literature. Medicine (Baltimore) 1986;65:312–321. - PubMed

Substances